持续暴露于顺铂后卵巢癌球体缩小是球体直径的函数
本研究用卵巢癌细胞系来源的小和大球体,比较模拟腹腔注射的短期高浓度顺铂与模拟植入装置的长期低浓度顺铂对球体缩小的影响,发现相同累积剂量下腹腔注射剂量更有效缩小大球体,而两种方案对小球的处理相似,且更高的累积装置剂量对缩小大球体最有效。
要点
- 相同累积剂量下,腹腔注射剂量比装置剂量更有效缩小大球体。
- 两种方案对小球体的缩小效果相似。
- 更高的累积装置剂量对缩小大球体最有效。
核心结论
- 结果支持腹腔注射治疗后瘤内药物分布受扩散控制的假说。
- 持续递送低剂量腹腔化疗的植入装置可能对微小肿瘤最有效。
研究设计与样本
- 研究使用UCI101和A2780细胞系来源的小和大卵巢癌球体。
- 球体暴露于模拟腹腔注射的短期高浓度顺铂或模拟植入装置的长期低浓度顺铂。
- 通过图像分析在不同时间点测量球体直径以量化肿瘤缩小。
主要发现
- 相同累积剂量下,腹腔注射剂量比装置剂量更有效缩小大球体。
- 两种方案对小球体的处理相似。
- 更高的累积装置剂量对缩小大球体最有效。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Most ovarian cancer patients present with advanced-stage disease, disseminated in the peritoneal cavity. Standard treatment involves surgical resection of all visible tumor, followed by delivery of systemic therapy. Patients with advanced-stage disease may be candidates for intraperitoneal (IP) chemotherapy following surgical debulking. Recent clinical trials have created controversy regarding the benefits of this approach. Previous clinical trials report that patients with microscopic residual disease respond best to IP therapy. The goal of this study was to determine the relationship between tumor size and the efficacy of continuous chemotherapy. METHODS: Small and large ovarian cancer spheroids (derived from UCI101 and A2780 cell lines) were exposed to short-term high (modeling an IP injection, "IP") or prolonged, low cisplatin concentrations (modeling an implanted device, "device"), which have been previously shown to be less toxic. Spheroid diameter was measured at various time points via image analysis and used to quantify tumor shrinkage over the course of treatment. RESULTS: We show that "IP" doses more effectively shrink large spheroids when the same cumulative dose is administered with both treatments, but that both regimens similarly treat small spheroids. We also demonstrate that higher cumulative "device" doses are most effective at shrinking large spheroids. CONCLUSIONS: These results support the hypothesis that intratumoral drug distribution following IP treatment is diffusion-controlled. An implanted device that continuously delivers low doses of IP chemotherapy would, therefore, be maximally effective against microscopic tumors.
引用
- Tanenbaum LM, Mantzavinou A, Subramanyam KS, et al. Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter. Gynecol Oncol. 2017. PMID: 28499648. doi:10.1016/j.ygyno.2017.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。